Bridge to surgery using partially covered self-expandable metal stents (PCMS) in malignant biliary stricture: an acceptable paradigm?
Background and aim
Partially covered self-expanding metal stents (PCMS) have been extensively used for palliation of malignant distal biliary stricture. Many centers have been using them as a bridge to surgery (BTS) regardless of resectability with or without eventual neoadjuvant therapy. We analyzed the outcome of all patients receiving PCMS and subsequently referred for surgery in our institution.
Our prospectively established pancreaticobiliary database was retrospectively analyzed to retrieve all patients with malignant biliary stricture who underwent PCMS placement and subsequently went for curative surgical attempt at our institution. Cancer type and staging, adverse events related to stent placement or surgery, type of surgery performed, time between stenting and surgery, length of postoperative hospitalization, and postoperative follow-up were recorded.
27 patients (21 men; median age 66 years, range 39–82 years) received PCMS. Indications for placement included biliary stricture related to pancreatic cancer (n = 23) or other malignancies (n = 4). Median time between stenting and surgery was 32 days (range 6–569 days). Median time of hospitalization post surgery was 7 days (1–40 days). All patients underwent exploratory laparoscopy, followed in 9 (33.3%) by Whipple procedure with uneventful removal of the PCMS. Eighteen patients (66.6%) had their attempted curative resection terminated early due to intraoperative evidence of metastatic spread, with 8 (30%) patients undergoing peritoneal or liver metastasis biopsy. PCMS were left in place in those 18 patients. Complications related to PCMS in the bridge-to-surgery period included migration (n = 2, 7.4%) and tissue overgrowth (n = 1, 3.4%), all of them managed by endoscopic removal and replacement with PCMS. Median follow-up post surgery was 210 days (range 9–1,642 days).
PCMS are an appropriate BTS option. For resectable patients, PCMS results in biliary drainage and allows for neoadjuvant treatment without portending subsequent curative resection (Whipple). For unresectable patients, long-term biliary drainage is provided by PCMS.
KeywordsPartially covered self-expandable metal stents Distal biliary malignant obstruction Whipple Bridge to surgery
Authors Pop, Richter, Sauer, Ho, Adams, Phillips, and Rehan have no conflicts of interest or financial ties to disclose. Dr. Bauer has received honoraria for lectures from IMER (Institute for Medical Education and Research). Dr. Shami is a consultant for Olympus. Dr. Kahaleh has received grant support from Boston Scientific, Olympus, Alveolus, Conmed, and Cook Medical, and honoraria for lectures from Boston Scientific, Olympus, and Axcan Pharma.
- 2.Smith AC, Dowsett JF, Russell RC. Hatfield AR, Cotton PB (1994) Randomized trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 344:1655–1660Google Scholar
- 9.Van der Gaag NA, Rauws EAJ, van Eijck CHJ, Bruno MJ, van der Harst E, Kubben FJGM, Gerritsen JJGM, Greve JW, Gerhards MF, de Hingh IHJT, Klinkenbijl JH, Nio CY, de Castro SMM, Busch ORC, van Gulik TM, Bossuyt PMM, Gouma DJ (2010) Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 362:129CrossRefPubMedGoogle Scholar
- 17.Vauthey JN, Dixon E (2009) AHPBA/SSO/SSAT Consensus conference on resectable and borderline resectable pancreatic cancer: rationale and overview of the conference. Ann Surg Oncol 16(7):1725–1726. Epub 2009 Apr 24Google Scholar